IR情報

2022/06/27~2022/11/21

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2022
11/214,6224,6654,6204,652+1.15%1,066,6002兆5950億+0.87%
11/184,5534,6004,5464,599+1.57%631,8002兆5654億-0.33%
11/174,5194,5524,5034,528+0.51%573,4002兆5258億-1.86%
11/164,5324,5414,4954,505-0.81%740,6002兆5130億-2.43%
11/154,5504,5734,5334,542+0.62%599,6002兆5336億-1.69%
11/144,5564,5914,5094,514-1.48%928,1002兆5180億-2.4%
11/114,6424,6434,5684,582+0.44%1,329,0002兆5560億-1.06%
11/104,5184,5744,5064,562+0.64%689,9002兆5448億-1.6%
11/094,5804,5864,5184,533-1.46%850,2002兆5286億-2.33%
11/084,5814,6244,5754,600+1.14%1,223,6002兆5660億-0.93%
11/074,6024,6104,5464,548-1.17%1,021,5002兆5370億-2.02%
11/044,6054,6594,5774,602-1.41%1,253,4002兆5671億-0.9%
11/024,6394,6834,6024,668+0.82%1,255,7002兆6039億+0.67%
11/014,6544,6894,6144,630-2.85%1,268,8002兆5827億+0.02%
10/3113:30 2022年12月期第3四半期決算短信〔IFRS〕(連結)
10/314,7384,7884,6554,766+1.75%1,647,5002兆6586億+3.14%
10/284,6714,7254,6534,684+0.15%3,895,0002兆6129億+1.63%
10/274,7054,7114,6484,677-0.17%943,6002兆6089億+1.63%
10/264,6024,7054,5924,685+2.34%1,011,2002兆6134億+1.91%
10/254,6014,6094,5674,578+0.55%949,7002兆5537億-0.26%
10/244,6484,6494,5434,553-1.04%817,6002兆5398億-0.78%
10/214,6124,6554,6014,601-1.14%830,9002兆5666億+0.28%
10/204,6424,6774,6344,654-0.56%896,1002兆5961億+1.42%
10/194,7164,7334,6704,680-0.45%684,9002兆6106億+1.98%
10/184,7464,7464,6814,701+1.03%1,040,3002兆6223億+2.46%
10/174,6804,6874,6314,653-1.15%871,9002兆5956億+1.51%
10/144,6634,7354,6214,707+2.48%1,302,5002兆6257億+2.84%
10/134,5964,6374,5694,593-0.07%765,2002兆5621億+0.5%
10/124,6004,6314,5844,596-0.02%872,5002兆5638億+0.68%
10/114,6144,6344,5614,597-1.27%1,137,1002兆5643億+0.75%
10/074,6464,6824,6264,656-0.43%925,8002兆5972億+2.11%
10/064,7024,7244,6584,676-0.26%838,7002兆6084億+2.63%
10/054,7004,7274,6644,688-0.02%974,3002兆6151億+3.03%
10/044,6214,6974,6134,689+2.25%1,069,3002兆6156億+3.17%
10/034,5744,5864,5214,586+0.04%1,026,5002兆5582億+0.99%
09/304,6124,6404,5574,584-0.07%1,759,1002兆5571億+0.92%
09/294,5164,6024,5024,587+3.17%1,244,7002兆5587億+0.99%
09/284,4284,4554,3984,446-0.49%1,536,5002兆4801億-2.16%
09/274,4354,4964,4344,468+0.9%856,6002兆4924億-1.93%
09/264,4214,4564,4004,428-0.94%1,301,9002兆4700億-2.98%
09/224,4574,4754,4104,470-0.49%1,146,3002兆4935億-2.32%
09/214,5084,5244,4744,492-1.19%773,2002兆5057億-2.03%
09/204,5324,5594,5264,546+0.35%887,5002兆5359億-1.04%
09/208:30 Paradise超音波腎デナベーションシステムTCT年次総会でRADIANCE-II米国ピボタル試験データを発表
09/164,5004,5464,4924,530-0.04%1,210,8002兆5269億-1.54%
09/154,5344,5414,4994,532-0.15%621,3002兆5281億-1.63%
09/144,5344,5544,5114,539-2.01%836,5002兆5320億-1.56%
09/1315:15 アリピプラゾール2カ月持続性注射剤統合失調症と双極I型障害の適応で米国FDAが申請受理
09/134,6584,6694,6284,632-0.24%555,5002兆5838億+0.37%
09/1215:00 抗精神病薬「ブレクスピプラゾール」大うつ病を対象とした国内フェーズ3試験で主要評価項目を達成
09/124,6614,6654,6154,643-0.24%566,0002兆5900億+0.56%
09/094,6024,6794,5994,654+1.2%1,347,9002兆5961億+0.8%
09/084,5674,6044,5594,599+2.38%1,002,0002兆5654億-0.35%
09/074,5474,5604,4534,492-0.77%1,008,7002兆5057億-2.64%
09/064,5134,5524,5064,527+1.18%754,1002兆5253億-1.93%
09/054,4664,4974,4404,474-1.37%840,3002兆4957億-3.26%
09/024,5514,5594,5024,536+0.22%873,3002兆5303億-2.16%
09/014,5304,5524,5204,526-0.77%660,4002兆5247億-2.69%
08/314,5094,5704,5094,561+0.62%1,282,9002兆5442億-2.25%
08/304,5554,5864,5284,533-0.37%677,3002兆5286億-3.12%
08/294,5314,5614,5094,550-1.11%781,0002兆5381億-3.11%
08/264,5974,6334,5884,601+0.17%463,7002兆5666億-2.36%
08/254,6054,6194,5674,593+0.17%621,6002兆5621億-2.83%
08/244,6044,6144,5574,585-1.46%730,6002兆5576億-3.29%
08/234,7244,7284,6334,653-1.84%906,4002兆5956億-2.08%
08/224,7094,7534,6544,740+1.56%861,1002兆6441億-0.46%
08/194,7054,7154,6624,667-0.98%730,1002兆6034億-2.16%
08/184,7134,7224,6644,713-0.13%1,138,3002兆6290億-1.42%
08/174,6684,7324,6504,719+0.53%1,018,6002兆6324億-1.48%
08/164,7134,7224,6624,694-0.68%656,2002兆6184億-2.21%
08/154,6854,7404,6824,726+0.81%563,9002兆6363億-1.71%
08/124,6894,7164,6654,688+1.49%1,293,7002兆6151億-2.72%
08/104,6554,6704,5824,619-0.54%1,019,0002兆5766億-4.35%
08/094,6774,7084,6284,644-0.77%841,0002兆5905億-4.05%
08/084,6354,6934,6224,680+0.45%744,8002兆6106億-3.49%
08/054,6114,6644,6004,659+1.53%1,188,8002兆5989億-4%
08/044,7194,7194,5544,589+0.22%1,239,4002兆5599億-5.56%
08/034,6484,6484,5624,579+0.53%1,265,2002兆5543億-5.94%
08/024,6704,6814,5504,555-3.86%1,045,8002兆5409億-6.7%
08/014,7224,7704,7114,738-0.34%1,013,3002兆6430億-3.15%
07/2913:30 2022年12月期第2四半期決算短信〔IFRS〕(連結)
07/294,9444,9484,6914,754-3.04%1,710,2002兆6519億-2.66%
07/284,8994,9204,8264,903+0.14%1,241,9002兆7350億+0.57%
07/274,8664,9134,7864,896+0.18%1,530,8002兆7311億+0.76%
07/2616:00 Paradise超音波腎デナベーションシステム高血圧患者対象のRADIANCE-II米国ピボタル試験にて主要評価項目を達成
07/2616:00 業績予想の修正に関するお知らせ
07/264,9424,9584,8764,887-1.39%792,9002兆7261億+0.97%
07/254,9554,9904,9234,956+0.08%665,1002兆7646億+2.8%
07/224,9764,9834,9004,952-0.52%797,3002兆7624億+3.23%
07/214,9024,9874,8994,978+0.79%840,9002兆7769億+4.27%
07/204,9064,9494,8794,939+1.56%955,3002兆7551億+4.04%
07/194,9024,9144,8384,863-1.1%645,5002兆7127億+2.92%
07/154,9414,9664,8984,917-0.43%866,0002兆7428億+4.42%
07/144,9104,9604,8754,938+0.2%915,3002兆7545億+5.31%
07/134,9374,9764,9154,928-0.36%809,4002兆7490億+5.52%
07/124,9544,9854,9244,946-0.76%1,058,4002兆7590億+6.37%
07/114,9495,0004,9204,984+2.15%1,163,9002兆7802億+7.72%
07/084,9504,9624,8324,879-2.42%1,593,5002兆7216億+6.02%
07/074,9725,0004,9235,000+1.32%1,391,0002兆7891億+9.15%
07/064,8674,9644,8604,935+0.8%1,508,2002兆7529億+8.39%
07/054,8814,8964,8304,896+0.29%1,055,0002兆7311億+8.06%
07/044,9004,9294,8404,882+2.37%1,104,4002兆7233億+8.32%
07/014,8584,9044,7534,769-1.02%1,080,5002兆6603億+6.28%
06/304,8154,8614,8114,818+0.27%1,439,5002兆6876億+7.81%
06/294,8504,8784,7934,805-2.63%1,703,8002兆6804億+7.95%
06/284,8094,9504,7974,935+2.88%1,611,7002兆7529億+11.27%
06/274,5674,8054,5184,797+5.38%2,104,9002兆6759億+8.6%
06/279:00 抗精神病薬「ブレクスピプラゾール」アルツハイマー型認知症に伴う行動障害を対象としたグローバルフェーズ3試験で主要評価項目を達成し有効性を確認